References
Baker, S. J.; Preisinger, A. C.; Jessup, J. M., et al. p53 Gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res. 50:7717–7722; 1990.
Ball, R. K.; Friis, R. R.; Shoenenberger, C. A., et al. Prolactin regulation of beta-casein gene expression and of a cytosolic 120 kd protein in a cloned mouse mammary epithelial cell line. EMBO J. 7:2089–2095; 1988.
Bischoff, J. R.; Casso, D.; Beach, D. Human p53 inhibits growth inSchizosaccharomyces pombe. Mol. Cell. Biol. 12:1405–1411; 1992.
Coles, C.; Condie, A.; Chetty, U., et al. p53 Mutations in breast cancer. Cancer Res. 52:5291–5298; 1992.
Danielson, K. G.; Knepper, J. E.; Kittrell, F. S., et al. Clonal populations of mouse mammary cell line COMMA-D, which retain capability of morphogenesis in vivo. In Vitro Cell. Dev. Biol. 25:535–543; 1989.
Danielson, K. G.; Oborn, C. J.; Durban, E. M., et al. Epithelial mouse mammary cell line exhibiting normal morphogenesisin vivo and functional differentiationin vitro. Proc. Natl. Acad. Sci. USA 81:3756–3760; 1984.
Friedrich, G.; Soriano, P. Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes & Dev. 5:1513–1523; 1991.
Hainaut, P.; Milner, J. A structural role for metal ions in the “wild-type” conformation of the tumor suppressor protein p53. Cancer Res. 53:1739–1742; 1993.
Jerry, D. J.; Butel, J. S. Direct sequencing of the complete murinep53 cDNA. Comments. United States Biochemical, 19:106, 123–125; 1993.
Jerry, D. J.; Ozbun, M. A.; Kittrell, F. S., et al. Mutations inp53 are frequent in the preneoplastic stage of mouse mammary tumor development. Cancer Res. 53:3374–3381; 1993.
Kittrell, F. S.; Oborn, C. J.; Medina, D. Development of mammary preneoplasiasin vivo from mouse mammary epithelial cell linesin vitro. Cancer Res. 52:1924–1932; 1992.
Kress, S.; Konig, J.; Schweizer, J., et al. p53 Mutations are absent from carcinogen-induced mouse liver tumors but occur in cell lines established from these tumors. Mol. Carcinogen. 6:148–158; 1992.
Lu, X.; Park, S. H.; Thompson, T. C., et al. ras-Induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation. Cell 70:153–161; 1992.
Medina, D.; Kittrell, F. S. Enhancement of tumorigenicity with morphological progression in a BALB/c preneoplastic outgrowth line. JNCI 79:569–576; 1987.
Medina, D.; Kittrell, F. S.; Oborn, C. J., et al. Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells. Cancer Res. 53:665–674; 1993.
Medina, D.; Li, M. L.; Oborn, C. J., et al. Casein gene expression in mouse mammary epithelial cell lines: dependence upon extracellular matrix and cell type. Exp. Cell Res. 172:192–203; 1987.
Medina, D.; Oborn, C. J.; Kittrell, F. S. Properties of mouse mammary epithelial cell lines characterized by in vivo transplantation and in vitro immunocytochemical methods. JNCI 76:1143–1156; 1986.
Ozbun, M. A.; Jerry, D. J.; Kittrell, F. S., et al.p53 Mutations selectedin vivo when mouse mammary epithelial cells form hyperplastic outgrowths are not necessary for establishment of mammary cellsin vitro. Cancer Res. 53:1646–1652; 1993.
Ozbun, M. A.; Medina, D.; Butel, J. S.p53 Mutations in mouse mammary epithelial cells: instability in culture and discordant selection of mutationsin vitro versusin vivo. Cell Growth Differen. 4: 811–819; 1993.
Sanger, F.; Nicklen, S.; Coulson, A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463–5467; 1977.
Schmidhauser, C.; Bissell, M. J.; Myers, C. A., et al. Extracellular matrix and hormones transcriptionally regulate bovine β-casein 5′ sequences in stably transfected mouse mammary cells. Proc. Natl. Acad. Sci. USA 87:9118–9122; 1990.
Thorlacius, S.; Borresen, A.-L.; Eyfjord, J. E. Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor. Cancer Res. 53:1637–1641; 1993.
Ziegler, A.; Leffell, D. J.; Kunala, S., et al. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc. Natl. Acad. Sci. USA 90:4216–4220; 1993.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jerry, D.J., Medina, D. & Butel, J.S. p53 Mutations in COMMA-D cells. In Vitro Cell Dev Biol - Animal 30, 87–89 (1994). https://doi.org/10.1007/BF02631398
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02631398